Cognitive & Nootropic Peptides

Cognitive and nootropic peptides target mood, anxiety, and cognitive recovery through distinct neuropeptide pathways. Selank is a GABA-pathway anxiolytic approved as a prescription medicine in Russia for generalized anxiety disorder; Semax acts through BDNF signaling and is approved in Russia and Ukraine for stroke recovery and cognitive impairment; Adamax is an ACTH(4-7) analogue with decades of Russian research behind it. Much of the human evidence across the 4 entries here comes from outside Western regulatory systems, which is worth weighing alongside the approval status itself.